← Back to Feed

/This biotech making precision medicines for cancer could nearly triple, says JPMorgan

This biotech making precision medicines for cancer could nearly triple, says JPMorgan

October 1, 2026 at 04:04 PM

Kura Oncology's pipeline of drugs show promise for the biotech stock.

Kura Oncology's pipeline of drugs show promise for the biotech stock.

Read the full article on CNBC

Read Full Article →

Home News Feed BLERBZ100 About

© 2026 Blerbz. All rights reserved. | Privacy | Terms

This biotech making precision medicines for cancer could nearly triple, says JPMorgan | Blerbz